Results 41 to 50 of about 14,984 (246)

Integrating the Gestalt Model of Self With Psychedelic‐Assisted Psychotherapy

open access: yesThe Journal of Humanistic Counseling, EarlyView.
ABSTRACT This theoretical integration paper employs a conceptual analysis methodology to synthesize the Gestalt model of self‐as‐process with Psychedelic Somatic Interactional Psychotherapy (PSIP). Unlike traditional psychedelic therapy models that defer therapeutic engagement to postsession integration, PSIP emphasizes an active, directive therapeutic
Travis R. Fox
wiley   +1 more source

Psychedelics for Moral Bioenhancement in Healthy Individuals—A Violation of the Non-Maleficence Principle?

open access: yesPsychoactives
Several authors have advanced the idea that psychedelics such as psilocybin might be effective means for achieving moral bioenhancement (MBE). Here, I discuss some reservations on this assertion from both neuropharmacological and bioethical perspectives,
Bor Luen Tang
doaj   +1 more source

HYPERSCALING HOUSING: Venture Capital, Real Estate Start‐Ups and the Race to Build a Global Residential Brand

open access: yesInternational Journal of Urban and Regional Research, EarlyView.
Abstract What happens when venture capitalists try to reinvent housing in their own image? Synonymous with the rise of Big Tech, venture capitalists (VCs) are asset managers that invest in early‐stage companies, pursuing aggressive growth and market domination. Since the 2008 financial crisis, VCs have poured huge sums into real estate start‐ups.
Tim White
wiley   +1 more source

Attitudes of European psychiatrists on psychedelics: a cross-sectional survey study

open access: yesScientific Reports
Research and public interest in psychedelic-assisted psychotherapy (PAP) are growing. This study investigated attitudes toward psychedelics among a diverse and multinational sample of psychiatrists currently working in Europe.
Marija Franka Žuljević   +4 more
doaj   +1 more source

Ethical and legal issues in psychedelic harm reduction and integration therapy

open access: yesHarm Reduction Journal, 2021
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits.
Brian Pilecki   +4 more
doaj   +1 more source

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice

open access: yesFrontiers in Psychology, 2021
Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context.
Ingmar Gorman   +11 more
doaj   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

Psychedelics and neonihilism: connectedness in a meaningless world

open access: yesFrontiers in Psychology, 2023
The resurgence of psychedelic research explicitly targets treating mental health conditions largely through psychedelics-assisted psychotherapy. Current theories about mechanisms of change in psychedelics-assisted psychotherapy focus on mystical ...
Patric Plesa, Rotem Petranker
doaj   +1 more source

Cognition, emotion, and the alcohol - Aggression relationship:Comment on Giancola (2000) [PDF]

open access: yes, 2000
P. R. Giancola's (2000) thesis that the alcohol-aggression relationship can be explained by alcohol-induced disruption of executive cognitive functions mediated by the prefrontal cortex is critically examined. At moderate doses, alcohol has been reported
Lyvers, M.
core   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy